Clinical trials
Suspended Phase 1/2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sclnow Biotechnology Co., Ltd. | 4 |
| Innovent Biologics (Suzhou) Co. Ltd. | 2 |
| Ascentage Pharma Group Inc. | 1 |
| HRYZ Biotech Co. | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| Peking Union Medical College Hospital | 1 |
| Ruijin Hospital | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Shanghai Minimally Invasive Surgery Center | 1 |
| Shengjing Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cerebral Infarction | 1 |
| Epstein-Barr Virus Infections | 1 |
| Femur Head Necrosis | 1 |
| Heart Failure | 1 |
| Hypoparathyroidism | 1 |
| Immunoblastic Lymphadenopathy | 1 |
| Leukemia | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.